News

Newsletter

Emergency measures derived from Covid-19: Brazilian Senate approves the postponement of Brazilian Data Protection Regulation

Last Friday, the Brazilian Senate deliberated about the Bill of Law no. 1,179/2020, which sets forth the Emergency and Transitory Legal Regime of relations in private law, based on the New Coronavirus (Covid-19) pandemic. Among its sections, there are two specific provisions that change the scenario of privacy and data protection in Brazil: the postponement of the effectiveness of Law no. 13,709/2020 (the Brazilian Data Protection Regulation – “LGPD”) to January 2021 and the application of the administrative sanctions to August of the same year. Originally, both would be applicable as of August 2020.
 
For further information, click below to access our full newsletter.
Back

Last related news

September 6, 2022

Brazilian National Health Surveillance Agency authorizes exceptional drug and vaccine use against Monkeypox by the Ministry of Health

The Ministry of Health (MH) sent Brazilian National Health Surveillance Agency (Anvisa) a request for exemption from the sanitary registration, on an Brazilian National Health Surveillance Agency authorizes exceptional drug and vaccine use against Monkeypox by the Ministry of Health

Ler notícia

August 16, 2022

Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

On August 8th, 2022, during the 12th Extraordinary Public Meeting of DICOL, ANVISA’s Collegiate Board of Directors announced the completion of the toxicological Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

Ler notícia

July 19, 2022

Carbendazim toxicological revaluation about to be completed by ANVISA

In December 2019, ANVISA started the process of toxicological revaluation of the Active Ingredient (AI) Carbendazim, as signs of toxicity were identified Carbendazim toxicological revaluation about to be completed by ANVISA

Ler notícia